Lista de obras -

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journal

artículo científico publicado en 2017

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

artículo científico

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study

scientific article published on 22 May 2009

An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway

artículo científico publicado en 2014

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial

artículo científico publicado en 2014

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study

artículo científico publicado en 2012

Can menopausal hormone therapy prevent coronary heart disease?

artículo científico publicado en 2008

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

scientific article published on 10 November 2018

Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7

scientific article published on 22 August 2019

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance

artículo científico publicado en 2013

Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids

scientific article published on 11 June 2019

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib

artículo científico publicado en 2009

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study

artículo científico publicado en 2013

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study

artículo científico publicado en 2015

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

artículo científico publicado en 2019

Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).

artículo científico publicado en 2017

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

artículo científico publicado en 2014

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

artículo científico publicado en 2013

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease

artículo científico publicado en 2014

Expression of Metabolic Syndrome in Women with Severe Obesity

artículo científico publicado en 2017

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

artículo científico publicado en 2013

Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese

artículo científico publicado en 2009

Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial

artículo científico publicado en 2020

Hyperlipoproteinemia type 3: the forgotten phenotype

artículo científico publicado en 2014

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

artículo científico publicado en 2021

Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback

scientific article published on 30 October 2019

Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women

artículo científico publicado en 2002

Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS).

artículo científico publicado en 2011

Is the WHI relevant to HRT started in the perimenopause?

scientific article published on 01 August 2004

Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence

artículo científico publicado en 2005

Lessons from KEEPS: the Kronos Early Estrogen Prevention Study

scientific article published on 03 September 2020

Letter by Jones et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation"

scientific article published on 01 June 2014

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.

artículo científico publicado en 2018

Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study

artículo científico

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study

artículo científico publicado en 2016

Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib

artículo científico publicado en 2012

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial

artículo científico publicado en 2010

Metabolic syndrome is associated with muscle symptoms among statin users.

artículo científico publicado en 2016

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study

artículo científico publicado en 2013

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

scientific article published on 19 August 2019

PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease

artículo científico publicado en 2018

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

artículo científico publicado en 2005

Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

artículo científico publicado en 2000

Postmenopausal hormone therapy: new questions and the case for new clinical trials

artículo científico publicado en 2006

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education

artículo científico publicado en 2013

Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey

artículo científico publicado en 2017

REDUCE-IT INTERIM: Accumulation of Data Across Prespecified Interim Analyses to Final Results

scientific article published on 03 October 2020

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States

scientific article published on 11 November 2019

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial

artículo científico publicado en 2017

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles

artículo científico publicado en 2019

Reduction in Revascularization with Icosapent Ethyl: Insights from REDUCE-IT REVASC

artículo científico publicado en 2020

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease ⬇️

artículo científico publicado el 17 de noviembre de 2010

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)

artículo científico publicado en 2013

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

artículo científico publicado en 2019

The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome

artículo científico publicado en 2015

The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition

artículo científico publicado en 2014

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

scientific article published on 01 April 2019

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition

scientific article published on 01 June 2004

The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred

artículo científico publicado en 2017

The importance of non-HDL cholesterol reporting in lipid management

artículo científico publicado en 2008

The time has come to flag and reduce excess fructose intake.

artículo científico publicado en 2016

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes

artículo científico publicado en 2011

Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?

artículo científico publicado en 2004

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users

artículo científico publicado en 2012

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

artículo científico publicado en 2009

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

artículo científico publicado en 2017

Women, hormones, and clinical trials: a beginning, not an end

artículo científico publicado en 2005

Lista de obras de

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journal

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study

An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study

Can menopausal hormone therapy prevent coronary heart disease?

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance

Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease

Expression of Metabolic Syndrome in Women with Severe Obesity

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese

Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial

Hyperlipoproteinemia type 3: the forgotten phenotype

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback

Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women

Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS).

Is the WHI relevant to HRT started in the perimenopause?

Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence

Lessons from KEEPS: the Kronos Early Estrogen Prevention Study

Letter by Jones et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation"

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.

Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study

Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial

Metabolic syndrome is associated with muscle symptoms among statin users.

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

Postmenopausal hormone therapy: new questions and the case for new clinical trials

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education

Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey

REDUCE-IT INTERIM: Accumulation of Data Across Prespecified Interim Analyses to Final Results

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles

Reduction in Revascularization with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease ⬇️

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome

The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition

The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred

The importance of non-HDL cholesterol reporting in lipid management

The time has come to flag and reduce excess fructose intake.

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes

Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Women, hormones, and clinical trials: a beginning, not an end